{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:58:17Z","timestamp":1788875897764,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.jcin.2020.04.027","type":"journal-article","created":{"date-parts":[[2020,8,12]],"date-time":"2020-08-12T16:21:47Z","timestamp":1597249307000},"page":"2024-2034","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Combination of F-ASO and Targeted Medical Therapy in Patients With Secundum ASD and Severe PAH"],"prefix":"10.1016","volume":"13","author":[{"given":"Chaowu","family":"Yan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangbin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyuan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2020.04.027_bib1","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jacc.2018.08.1028","article-title":"2018 AHA\/ACC guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Stout","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2020.04.027_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.athoracsur.2005.07.053","article-title":"Hypertensive pulmonary vascular disease in adults with secundum or sinus venosus atrial septal defect","volume":"81","author":"JS1","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jcin.2020.04.027_bib3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijcard.2019.03.056","article-title":"\u201cTreat-to-close\u201d: non-repairable ASD-PAH in the adult: results from the North American ASD-PAH (NAAP) Multicenter Registry","volume":"291","author":"Bradley","year":"2019","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcin.2020.04.027_bib4","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1093\/eurheartj\/eht437","article-title":"Pulmonary hypertension related to congenital heart disease: a call for action","volume":"35","author":"Dimopoulos","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2020.04.027_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1253\/circj.CJ-15-0599","article-title":"Treat and repair strategy in patients with atrial septal defect and significant pulmonary arterial hypertension","volume":"80","author":"Kijima","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.jcin.2020.04.027_bib6","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.106.630715","article-title":"Bosentan therapy in patients with Eisenmenger syndrome: a multicenter, double-blind, randomized, placebo-controlled study","volume":"114","author":"Gali\u00e8","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.jcin.2020.04.027_bib7","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial use of ambrisentan plus tadalafil in pulmonary arterial hypertension","volume":"373","author":"Gali\u00e8","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2020.04.027_bib8","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.amjcard.2010.12.051","article-title":"Ambrisentan for pulmonary arterial hypertension due to congenital heart disease","volume":"107","author":"Zuckerman","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2020.04.027_bib9","first-page":"564","article-title":"Shunt reduction with a fenestrated Amplatzer device","volume":"76","author":"Kretschmar","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2020.04.027_bib10","first-page":"1329","article-title":"Fenestrated ASD device \u201cangioplasty\u201d: how to adjust a \u201cpop-off\u201d mechanism when needed","volume":"92","author":"Tufaro","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2020.04.027_bib11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/chd.12367","article-title":"Fenestrated transcatheter ASD closure in adults with diastolic dysfunction and\/or pulmonary hypertension: case series and review of the literature","volume":"11","author":"Abdelkarim","year":"2016","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.jcin.2020.04.027_bib12","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1540-8183.2007.00324.x","article-title":"Fenestrated occluders for treatment of ASD in elderly patients with pulmonary hypertension and\/or right heart failure","volume":"21","author":"Bruch","year":"2008","journal-title":"J\u00a0Interv Cardiol"},{"key":"10.1016\/j.jcin.2020.04.027_bib13","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.jtcvs.2018.11.093","article-title":"Off-label use of duct occluder in transcatheter closure of secundum atrial septal defect with no rim to right pulmonary vein","volume":"157","author":"Yan","year":"2019","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jcin.2020.04.027_bib14","first-page":"1309","article-title":"Three-dimensional printing assisted transcatheter closure of atrial septal defect with deficient posterior-inferior rim","volume":"92","author":"Yan","year":"2018","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2020.04.027_bib15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCINTERVENTIONS.108.826560","article-title":"Pulmonary arterial hypertension in patients with transcatheter closure of secundum atrial septal defects: a longitudinal study","volume":"2","author":"Yong","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2020.04.027_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2020.04.027_bib17","article-title":"Usefulness of mean pulmonary artery pressure for predicting outcomes of transcatheter closure of atrial septal defect with pulmonary arterial hypertension.","author":"Pan","year":"2019","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2020.04.027_bib18","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.ijcard.2014.08.009","article-title":"A\u00a0different view on predictors of pulmonary hypertension in secundum atrial septal defect","volume":"176","author":"Gabriels","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcin.2020.04.027_bib19","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.amjcard.2013.07.027","article-title":"Usefulness of medical therapy for pulmonary hypertension and delayed atrial septal defect closure","volume":"112","author":"Bradley","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jcin.2020.04.027_bib20","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ijcard.2010.10.051","article-title":"Bosentan-sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology","volume":"155","author":"D\u2019Alto","year":"2012","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcin.2020.04.027_bib21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00380-013-0351-0","article-title":"Subsequent shunt closure after targeted medical therapy can be an effective strategy for secundum atrial septal defect with severe pulmonary arterial hypertension: two case reports: strategy for ASD with severe PAH","volume":"29","author":"Taniguchi","year":"2014","journal-title":"Heart Vessels"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879820309730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879820309730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:11:57Z","timestamp":1761847917000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879820309730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":21,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1936879820309730"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2020.04.027","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination of F-ASO and Targeted Medical Therapy in Patients With Secundum ASD and Severe PAH","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2020.04.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}